Key facts
- Notable investors include Innovation Authority, Dhuna Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Reverto bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Reverto bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Reverto bio
Operator of a biomedical technology company focused on cell reprogramming and skin condition treatment. The company combines experimentally validated artificial intelligence models with experimental biology to predict gene expression changes, enabling drug discovery and therapeutic research across dermatological and immune related disease areas.
- Sector
- Healthcare
- HQ
- Ramat Gan, Israel
- Founded
- 2025
- Employees
- 5
- Website
- reverto.bio/
- Ownership
- Privately Held (backing)
Reverto bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Reverto bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Reverto bio in its N-PORT filings yet. We sweep new filings monthly.